Stefan Johannes Lehner

Title: The Innovations of Stefan Johannes Lehner

Introduction

Stefan Johannes Lehner is a notable inventor based in Wiesbaden, Germany. He has made significant contributions to the field of veterinary medicine, particularly in the treatment of systemic diseases in cats. With a total of 12 patents to his name, his work has had a profound impact on animal health.

Latest Patents

Among his latest patents is an innovative method for the prophylaxis or treatment of hypertension in cats. This method involves the administration of a therapeutically effective amount of angiotensin II receptor 1 (AT-1) antagonist, commonly known as a sartan. The treatment protocol includes varying the daily dosage amount over a specified treatment period, ensuring optimal care for the feline patients. Another significant patent involves a liquid preparation comprising pimobendan, which includes an etherified cyclodextrin derivative and a substituted benzimidazol. This formulation aims to enhance the therapeutic efficacy for veterinary applications.

Career Highlights

Stefan has worked with prominent companies in the veterinary field, including Boehringer Ingelheim Vetmedica GmbH. His expertise and innovative approaches have positioned him as a leader in developing effective treatments for animals.

Collaborations

Throughout his career, Stefan has collaborated with esteemed colleagues such as Martin Andreas Folger and Detlef Mohr. These partnerships have fostered a collaborative environment that encourages the advancement of veterinary medicine.

Conclusion

Stefan Johannes Lehner's contributions to veterinary medicine through his patents and collaborations highlight his commitment to improving animal health. His innovative methods and formulations continue to pave the way for advancements in the treatment of systemic diseases in cats.